TEM240719P30000
- 2.30
- +1.05+84.00%
Tempus AI Newsroom
Express News | Tempus AI, Inc. Reports 15.1% Stake in Personalis Inc as of July 3, 2024-SEC Filing
Why Tempus AI (TEM) Stock Is Rising
Tempus AI Inc (NASDAQ:TEM) shares are trading higher by 7.45% to $35.82 during Tuesday's session after the company announced it was granted Advanced Diagnostic Laboratory Test (ADLT) status for its ne
Tempus AI Shares Are Trading Higher After the Company Announced It Was Granted Advanced Diagnostic Laboratory Test Status for Its Next-generation Sequencing Assay From the Centers for Medicare & Medicaid Services.
Tempus AI Shares Are Trading Higher After the Company Announced It Was Granted Advanced Diagnostic Laboratory Test Status for Its Next-generation Sequencing Assay From the Centers for Medicare & Medic
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for Its XT CDx Test
Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted Advanced Diagnostic Laboratory Test
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Tempus AI, Inc. (NASDAQ:TEM) shares jumped 30.43% after the company announced it received U.S. FDA 510(k) cle
Express News | Tempus AI Rises for Third Straight Session, Last up 7.3%
SoftBank raised $1.86 billion in overseas bond financing for Masayoshi Son's AI project "bursting with gold coins".
SoftBank Group raised approximately USD 1.86 billion through the issuance of US dollar bonds and euro bonds. Last week, Masayoshi Son made a tough statement, saying that he is ready to bet on AI whether he wins or loses.
SoftBank Group Launches AI Healthcare Joint Venture With Tempus AI
Tempus Wins FDA Nod for AI-backed Heart Diagnostic
Tempus AI Gets 510(k) Clearance for ECG-AF Device
By Chris Wack Tempus AI said it received 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECG-AF device, which uses artificial intelligence to help identify patients who may
Express News | Tempus Receives U.S. FDA 510(K) Clearance for Tempus Ecg-Af, an AI-Based Algorithm That Identifies Patients at Increased Risk of Afib
This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan
SoftBank Group (OTC:SFTBY) (OTC:SFTBF) is set to introduce a medical service in Japan that uses artificial intelligence to analyze personal medical data, including genetic information. The service wil
Express News | Tempus AI Inc: Collaboration With United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension
Express News | SoftBank Group to Set up Medical Data Joint Venture With US-Based Tempus AI -Nikkei
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results.Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, be
Express News | Shares of SoftBank-Backed Tempus AI Down More Than 16%, Well Below IPO Price in Their Third Day of Trading
Tempus AI Shares Are Trading Lower Amid Post-IPO Volatility.
Tempus AI Shares Are Trading Lower Amid Post-IPO Volatility.
Tempus AI Prices 11.1M Share IPO at $37/sh
Futu Morning News | Strong upward trend! The S&P 500 index is called by institutions to reach 6000 points; "Hawkish" still exists! Federal Reserve officials: Whether to reduce interest rates still depends on several more data.
Microsoft, Nvidia and Nasdaq continue to refresh their highs, while the S&P index's bullish trend takes a pause; Adobe soared over 14%, and its target price was raised by several major banks after its earnings report; The first batch of generative AI application companies went public, and the "medical diagnosis" Tempus AI rose nearly 9% on its first day of trading.
The first batch of generative AI application companies are listed. Tempus AI's "medical diagnosis" rose nearly 9% on its first day of listing.
AI technology is gradually infiltrating the medical industry. On Friday, the Nasdaq stock market welcomed a medical diagnostics company named Tempus AI. The company uses AI to help doctors analyze patients' medical test data. The stock price rose by 18% on the first day of its IPO.